| ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells DW Lee, BD Santomasso, FL Locke, A Ghobadi, CJ Turtle, JN Brudno, ... Biology of blood and marrow transplantation 25 (4), 625-638, 2019 | 2735 | 2019 |
| A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma DM O’Rourke, MLP Nasrallah, A Desai, JJ Melenhorst, K Mansfield, ... Science translational medicine 9 (399), eaaa0984, 2017 | 1718 | 2017 |
| Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma N Raje, J Berdeja, YI Lin, D Siegel, S Jagannath, D Madduri, M Liedtke, ... New England Journal of Medicine 380 (18), 1726-1737, 2019 | 1671 | 2019 |
| Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma GP Linette, EA Stadtmauer, MV Maus, AP Rapoport, BL Levine, L Emery, ... Blood, The Journal of the American Society of Hematology 122 (6), 863-871, 2013 | 1316 | 2013 |
| Antibody-modified T cells: CARs take the front seat for hematologic malignancies MV Maus, SA Grupp, DL Porter, CH June Blood, The Journal of the American Society of Hematology 123 (17), 2625-2635, 2014 | 1090 | 2014 |
| Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce antitumor activity in solid malignancies GL Beatty, AR Haas, MV Maus, DA Torigian, MC Soulen, G Plesa, ... Cancer immunology research 2 (2), 112-120, 2014 | 974 | 2014 |
| CD8+ T-cell responses to adeno-associated virus capsid in humans F Mingozzi, MV Maus, DJ Hui, DE Sabatino, SL Murphy, JEJ Rasko, ... Nature medicine 13 (4), 419-422, 2007 | 854 | 2007 |
| Recent advances and discoveries in the mechanisms and functions of CAR T cells RC Larson, MV Maus Nature Reviews Cancer 21 (3), 145-161, 2021 | 714 | 2021 |
| T cells expressing chimeric antigen receptors can cause anaphylaxis in humans MV Maus, AR Haas, GL Beatty, SM Albelda, BL Levine, X Liu, Y Zhao, ... Cancer immunology research 1 (1), 26-31, 2013 | 710 | 2013 |
| Chimeric antigen receptor T cells against CD19 for multiple myeloma AL Garfall, MV Maus, WT Hwang, SF Lacey, YD Mahnke, JJ Melenhorst, ... New England Journal of Medicine 373 (11), 1040-1047, 2015 | 685 | 2015 |
| Engineered CRISPR–Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing BP Kleinstiver, AA Sousa, RT Walton, YE Tak, JY Hsu, K Clement, ... Nature biotechnology 37 (3), 276-282, 2019 | 646 | 2019 |
| Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB MV Maus, AK Thomas, DGB Leonard, D Allman, K Addya, K Schlienger, ... Nature biotechnology 20 (2), 143-148, 2002 | 624 | 2002 |
| Dominant-negative TGF-β receptor enhances PSMA-targeted human CAR T cell proliferation and augments prostate cancer eradication CC Kloss, J Lee, A Zhang, F Chen, JJ Melenhorst, SF Lacey, MV Maus, ... Molecular therapy 26 (7), 1855-1866, 2018 | 589 | 2018 |
| Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery L Tang, Y Zheng, MB Melo, L Mabardi, AP Castaño, YQ Xie, N Li, ... Nature biotechnology 36 (8), 707-716, 2018 | 584 | 2018 |
| Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia JA Fraietta, KA Beckwith, PR Patel, M Ruella, Z Zheng, DM Barrett, ... Blood, The Journal of the American Society of Hematology 127 (9), 1117-1127, 2016 | 529 | 2016 |
| Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastoma LA Johnson, J Scholler, T Ohkuri, A Kosaka, PR Patel, SE McGettigan, ... Science translational medicine 7 (275), 275ra22-275ra22, 2015 | 528 | 2015 |
| CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity BD Choi, X Yu, AP Castano, AA Bouffard, A Schmidts, RC Larson, ... Nature biotechnology 37 (9), 1049-1058, 2019 | 498 | 2019 |
| Engineering and design of chimeric antigen receptors S Guedan, H Calderon, AD Posey, MV Maus Molecular Therapy-Methods & Clinical Development 12, 145-156, 2019 | 454 | 2019 |
| Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig–coated artificial antigen-presenting cells M Oelke, MV Maus, D Didiano, CH June, A Mackensen, JP Schneck Nature medicine 9 (5), 619-625, 2003 | 413 | 2003 |
| The emerging landscape of immune cell therapies EW Weber, MV Maus, CL Mackall Cell 181 (1), 46-62, 2020 | 405 | 2020 |
Carl JuneUniversity of Pennsylvaniaبريد إلكتروني تم التحقق منه على upenn.edu
